Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results

Eurosurveillance

Volumn , Issue 27, 2014, Pages

  Andrews, N ^a   McMenamin, J ^b   Durnall, H ^a,c   Ellis, J ^a   Lackenby, A ^a   Robertson, C ^b,d,e   von Wissmann, B ^b   Cottrell, S ^f   Smyth, B ^g   Moore, C ^f   Gunson, R ^h   Zambon, M ^a   Fleming, D ^c   Pebody, R ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b HEALTH PROTECTION SCOTLAND   (United Kingdom)

^c ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^e INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^f PUBLIC HEALTH WALES   (United Kingdom)

^g PUBLIC HEALTH AGENCY   (United Kingdom)

^h West of Scotland Specialist Virology Laboratory Gartnavel   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; TRIVALENT SEASONAL INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; DNA SEQUENCE; DRUG EFFICACY; HUMAN; INFANT; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MIDDLE AGED; NEWBORN; PHYLOGENETIC TREE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; RESPIRATORY VIRUS; SEASON; SEASONAL INFLUENZA; UNITED KINGDOM; VIRUS STRAIN; WORLD HEALTH ORGANIZATION; FEMALE; MAJOR CLINICAL STUDY; MALE; PHYLOGENY; SEASONAL VARIATION; SYMPTOM; VACCINATION;

EID: 84928187904     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.es2014.19.27.20851     Document Type: Article

References (21)

1. Public Health England (PHE). Surveillance of influenza and other respiratory viruses, including novel respiratory viruses, in the United Kingdom: Winter 2012/13. London: PHE; Jun 2013. Available from http://www.hpa.org.uk/Publications/InfectiousDiseases/Influenza/1306influseasonalannualreport/.
2. Pebody R, Andrews N, McMenamin J, Durnall H, Ellis J, Thompson CI, et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill. 2013;18(5):pii=20389.
3. McMenamin J, Andrews N, Robertson C, Fleming D, Durnall H, von Wissmann B, et al. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. Euro Surveill. 2013;18(5):pii=20393.
4. Valenciano M, Kissling E; I-MOVE Case-Control Study Team. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill. 2013;18(7): pii=20400.
5. Skowronski DM, Janjua NZ, De Serres G, Dickinson JA, Winter AL, Mahmud SM, et al.Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro Surveill. 2013;18(5):pii= 20394.
6. Pebody RG, Andrews N, Fleming DM, McMenamin J, Cottrell S, Smyth B, et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiol Infect. 2013;141(3):620-30. http://dx.doi.org/10.1017/S0950268812001148.
7. Hardelid P, Fleming DM, McMenamin J, Andrews NJ, Robertson C, Sebastianpillai P, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill. 2011;16(2):pii=19763.
8. Ellis J, Iturriza M, Allen R, Bermingham A, Brown K, Gray J, et al. Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Euro Surveill. 2009;14(22):pii=19230.
9. Gunson R, Maclean A, Davies E, Bennett S, Miller R, Carman WF. Development of a multiplex real-time RT- PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus. J Virol Methods. 2010;163(2):258-61. http://dx.doi.org/10.1016/j.jviromet.2009.10.006.
10. Matrosovich M, Matrosovich T, Carr J, Roberts NA, Klenk HD. Overexpression of the alpha-2,6- sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol. 2003;77(15):8418-25. http://dx.doi.org/10.1128/JVI.77.15.8418-8425.2003.
11. Zambon M. Laboratory Diagnosis of Influenza. In: Nicholson K, Hay A, Webster RG, editors. Textbook of Influenza. Oxford: Blackwell Science; 1998. pp. 291-313.
12. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007;36(3):623-31. http://dx.doi.org/10.1093/ije/dym021.
13. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2013-2014 northern hemisphere influenza season. Geneva: WHO; 21 Feb 2013. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/.
14. Pebody R, Hardelid P, Fleming D, McMenamin J, Andrews N, Robertson C, et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill. 2011;16(6): pii=19791.
15. Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiology Community Health. 2010;64(12), 1062-7. http://dx.doi.org/10.1136/jech.2009.093450.
16. Ferdinands JM, Belongia EA, Nwasike C, Shay DK. Influenza vaccination status is not associated with influenza testing among children: Implications for observational studies of vaccine effectiveness. Vaccine. 2011;29(10):1935-40. http://dx.doi.org/10.1016/j.vaccine.2010.12.098.
17. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine. 2010;28(46):7381-8. http://dx.doi.org/10.1016/j.vaccine.2010.09.010.
18. De Serres G, Skowronski D, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill. 2013;18(37):pii=20585.
19. Health Protection Agency (HPA). Surveillance of influenza and other respiratory pathogens in the UK, 2011/12. London: HPA; Jun 2012. Available from: http://www.hpa.org.uk/Publications/InfectiousDiseases/Influenza/1206influannualreport/.
20. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill. 2013;18(5):pii=20390.
21. Hakin B, Coford P, Harvey F. Children's flu immunisation programme 2013-14. London: Department of Health and Publich Health England; 26 July 2013. Available from https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/225360/Children_s_flu_letter_2013.pdf.